Physician Perspectives on Including Pregnant Women in Covid-19 Clinical Trials: Time for a Paradigm Change.

Covid-19 clinical trials human subjects research inclusion of pregnant women in trials maternal-fetal ethics pregnant research participants research with pregnant women

Journal

Ethics & human research
ISSN: 2578-2363
Titre abrégé: Ethics Hum Res
Pays: United States
ID NLM: 101738005

Informations de publication

Date de publication:
Nov 2021
Historique:
pubmed: 27 10 2021
medline: 11 11 2021
entrez: 26 10 2021
Statut: ppublish

Résumé

Excluding pregnant people from Covid-19 clinical trials may lead to unintended harmful consequences. For this study, an online questionnaire was sent to physicians belonging to Canadian professional medical associations in order to evaluate their perspectives on the participation of pregnant women in Covid-19 clinical trials. The majority of respondents expressed support for including pregnant women in Covid-19 trials (119/165; 72%), especially those investigating therapies with a prior safety record in pregnancy (139/164; 85%). The main perceived barriers to inclusion identified were unwillingness of pregnant patients to participate and of treating teams to offer participation, the burden of regulatory approval, and a general "culture of exclusion" of pregnant women from trials. We describe why some physicians may be reluctant to include pregnant individuals in trials, and we identify barriers to the appropriate participation of pregnant people in clinical research.

Identifiants

pubmed: 34699138
doi: 10.1002/eahr.500107
pmc: PMC8652879
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

19-27

Informations de copyright

© 2021 by The Hastings Center. All rights reserved.

Références

Hastings Cent Rep. 2017 May;47(3):38-45
pubmed: 28543423
Obstet Gynecol. 2013 Nov;122(5):1077-1081
pubmed: 24104789
Ann Intern Med. 2020 Nov 17;173(10):836-837
pubmed: 32598164
MMWR Morb Mortal Wkly Rep. 2020 Sep 25;69(38):1347-1354
pubmed: 32970655
Int J Fem Approaches Bioeth. 2008 Fall;1(2):5-22
pubmed: 19774226
J Med Internet Res. 2004 Sep 29;6(3):e34
pubmed: 15471760
Open Forum Infect Dis. 2020 Aug 13;7(9):ofaa350
pubmed: 32929403
MMWR Morb Mortal Wkly Rep. 2020 Jun 26;69(25):769-775
pubmed: 32584795
IRB. 2012 Jul-Aug;34(4):1-8
pubmed: 22893991
Womens Health Issues. 2013 Jan;23(1):e39-45
pubmed: 23312713
Vaccine. 2020 Oct 14;38(44):6922-6929
pubmed: 32893036
J Med Ethics. 2017 Oct;43(10):657-663
pubmed: 28716977
CMAJ. 2020 Apr 14;192(15):E405-E407
pubmed: 32336678

Auteurs

Marie-Julie Trahan (MJ)

Obstetrics and gynecology resident at McGill University.

Annabelle Cumyn (A)

Professor of medicine and an obstetric medicine specialist in the Department of Medicine in the Centre Hospitalier Universitaire de Sherbrooke.

Matthew P Cheng (MP)

Assistant professor of medicine and an infectious diseases and medical microbiology specialist in the Department of Medicine at McGill University Health Centre and the Research Institute of the McGill University Health Centre.

Emily G McDonald (EG)

Associate professor of medicine and an internist in the Department of Medicine at McGill University Health Centre and the Research Institute of the McGill University Health Centre.

Stephen E Lapinsky (SE)

Professor of medicine and critical care specialist in the Department of Medicine at Mount Sinai Hospital, Toronto.

Nick Daneman (N)

Clinician scientist and infectious disease specialist in the Department of Medicine at Sunnybrook Health Sciences Centre, Toronto.

Haim A Abenhaim (HA)

Associate professor and maternal-fetal medicine specialist in the Department of Obstetrics and Gynecology at McGill University and in the Department of Obstetrics and Gynecology and Lady David Research Institute at Jewish General Hospital in Montreal.

Isabelle Malhamé (I)

Assistant professor of medicine and an obstetric medicine specialist in the Department of Medicine at McGill University Health Centre and the Research Institute of the McGill University Health Centre.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH